Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

2142 - Low NK Cell Abundance Correlates with High Expression of PD-1 in CD8+ T Cells


30 Sep 2019


Poster Display session 3


Translational Research

Tumour Site


Moon Hee Lee


Annals of Oncology (2019) 30 (suppl_5): v760-v796. 10.1093/annonc/mdz268


M.H. Lee1, P. Järvinen2, H. Nísen2, O. Bruck1, M. Ilander1, S. Mustjoki1, A. Kreutzman1

Author affiliations

  • 1 Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki, Helsinki University Central Hospital Comprehensive Cancer Center, 00290 - Helsinki/FI
  • 2 Department Of Urology, Peijas Hospital, Helsinki University Hospital, University of Helsinki, 01400 - Vantaa/FI


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2142


Renal cell carcinoma (RCC) is considered an immunogenic cancer with a high frequency of indel mutations, immuno-oncological (IO) sensitivity, and infiltration of T cells. Because natural killer (NK) cells are a lesser known population compared to their T cell counterparts, we aimed to investigate the intratumoral phenotype of the cells to assess the overall immune landscape of RCC.


The tumor, matching peripheral blood (PB) and healthy kidney tissue samples were obtained from 40 RCC patients that underwent radical nephrectomy and were phenotyped using multi-parameter flow cytometry and a comprehensive immunostaining panel containing 56 fundamental markers to cancer immunology.


Using hierarchical clustering and correlation analysis, we discovered that our cohort clustered into two distinct subgroups defined by the abundance of NK cells from the intratumoral lymphocyte population, defined as NKhigh (n = 17; mean 24.3%) and NKlow (n = 18; mean 7.5%). Consequently, an increased abundance of NK cells correlated with a lower expression of PD-1, particularly in the CD8+ T cells (r=-0.5722, p = 0.0003), but not with LAG-3. Contrastingly, clinical parameters such as tumor grade, gender and age did not differ between the two NK subgroups. However, patients with high NK cell abundance significantly had more often necrosis present in the tumors (p = 0.04). We also independently phenotyped two regions of the same tumor sample (n = 10) to compare the periphery and core lymphocytes. Surprisingly, both spatially different regions displayed similar quantities of immune cell populations and immunophenotypic markers. Overall, the tumor immune landscape in RCC resulted in a proportion of tumors carrying a higher abundance of NK cells than their T cell-rich corresponding PB and healthy tissue samples, which supports our findings that a proportion of tumors accumulate NK cells.


Our study has led to the discovery of two distinct RCC tumoral NK cell subgroups, NKhigh and NKlow. Next, we aim to further explore the transcriptional differences of the two subgroups with ongoing bulk RNA sequencing (RNAseq). Furthermore, prospective single-cell RNA sequencing (sc-RNAseq) will be carried out to investigate the immunological heterogeneities in higher resolution.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


University of Helsinki, Hematology Research Unit Helsinki.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.